Journal of Cardiothoracic and Vascular Anesthesia
Volume 23, Issue 1 , Pages 28-33 , February 2009

Recombinant Factor VIIa Treatment of Severe Bleeding in Cardiac Surgery Patients: A Retrospective Analysis of Dosing, Efficacy, and Safety Outcomes

  • Faisal Masud, MD, FCCP

      Affiliations

    • Methodist Hospital, Houston, TX
    • Corresponding Author InformationAddress reprint requests to Faisal Masud, MD, FCCP, Department of Anesthesiology, Methodist Hospital, 6565 Fannin Street, B452, Houston, TX 77030
    • ,
  • Fariedeh Bostan, PharmD

      Affiliations

    • Methodist Hospital, Houston, TX
    • ,
  • Elisa Chi, PharmD

      Affiliations

    • Methodist Hospital, Houston, TX
    • ,
  • Steven E. Pass, PharmD, FCCM

      Affiliations

    • University of Houston College of Pharmacy, Houston, TX
    • ,
  • Hany Samir, MD

      Affiliations

    • Methodist Hospital, Houston, TX
    • ,
  • Karla Stuebing, PhD

      Affiliations

    • University of Houston TIMES, Houston, TX
    • ,
  • Michael G. Liebl, PharmD

      Affiliations

    • Methodist Hospital, Houston, TX

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 F.M. received a research grant from NovoNordisk, manufacturers of recombinant factor VIIa, in the amount of $5,000.00.

PII: S1053-0770(08)00235-8

doi: 10.1053/j.jvca.2008.08.003

Journal of Cardiothoracic and Vascular Anesthesia
Volume 23, Issue 1 , Pages 28-33 , February 2009

Article Tools

* Image Usage & Resolution